KHA Releases One-Pager Supporting SB 27

Share

Protect Private Money Providing Patient Access

The 340B drug discount program is a privately funded, federally administered system. The program allows non-profit, safety-net hospitals to purchase outpatient medications from pharmaceutical manufacturers at the same price the manufacturers charge their best customers – NOT for free.

Pharmaceutical manufacturers, which continue to have record profits, agreed to fund the 340B program in order to be a part of Obamacare. Now they want to back out of that commitment. Their refusal to ship prescription drugs comes at the expense of the poorest and most vulnerable patients being served by 340B hospitals.

The savings from the program help Kentucky hospitals to maintain access to care and make it possible for hospitals to offer additional services to their patients.

Latest News

News
April 1, 2025
Join your colleagues for the Spring Listening Tour as the KHA team travels around the state to connect directly with members!
News
March 25, 2025
The Kentucky Trustee is a quarterly newsletter KHA produces for hospital boards.
Awards
March 21, 2025
KHA presented its annual Quality Awards during the Quality Conference award luncheon on Wednesday, March 19.